City of Hope Enters Licensing Agreement With Chimeric to Develop Its Pioneering Chlorotoxin CAR T Cell Therapy

DUARTE, Calif.–(BUSINESS WIRE)– #CityofHope–City of Hope licensed intellectual property relating to its chlorotoxin chimeric antigen receptor T cell therapy to Chimeric Therapeutics Limited.